235 related articles for article (PubMed ID: 37240019)
1. Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma.
Nitsch A; Qarqash S; Römer S; Schoon J; Ekkernkamp A; Niethard M; Reichert JC; Wassilew GI; Tzvetkov MV; Haralambiev L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240019
[TBL] [Abstract][Full Text] [Related]
2. Effective combination of cold physical plasma and chemotherapy against Ewing sarcoma cells in vitro.
Nitsch A; Qarqash S; Römer S; Schoon J; Singer D; Bekeschus S; Ekkernkamp A; Wassilew GI; Tzvetkov MV; Haralambiev L
Sci Rep; 2024 Mar; 14(1):6505. PubMed ID: 38499701
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
Boehme KA; Nitsch J; Riester R; Handgretinger R; Schleicher SB; Kluba T; Traub F
Int J Oncol; 2016 Nov; 49(5):2135-2146. PubMed ID: 27665785
[TBL] [Abstract][Full Text] [Related]
4. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
5. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
[TBL] [Abstract][Full Text] [Related]
6. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
Benini S; Manara MC; Baldini N; Cerisano V; Massimo Serra ; Mercuri M; Lollini PL; Nanni P; Picci P; Scotlandi K
Clin Cancer Res; 2001 Jun; 7(6):1790-7. PubMed ID: 11410521
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
[TBL] [Abstract][Full Text] [Related]
9. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
Wagner MJ; Gopalakrishnan V; Ravi V; Livingston JA; Conley AP; Araujo D; Somaiah N; Zarzour MA; Ratan R; Wang WL; Patel SR; Lazar A; Ludwig JA; Benjamin RS
Oncologist; 2017 Oct; 22(10):1271-1277. PubMed ID: 28710342
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines.
Hofbauer S; Hamilton G; Theyer G; Wollmann K; Gabor F
Eur J Cancer; 1993; 29A(2):241-5. PubMed ID: 8380698
[TBL] [Abstract][Full Text] [Related]
11. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
[TBL] [Abstract][Full Text] [Related]
12. Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines.
Lenz JE; Riester R; Schleicher SB; Handgretinger R; Boehme KA; Traub F
Oncol Rep; 2020 Jan; 43(1):337-345. PubMed ID: 31746397
[TBL] [Abstract][Full Text] [Related]
13. In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation.
Gulati SC; Kwon JH; Atzpodien J; Triche TJ; Colvin OM; Clarkson BD
Cancer Invest; 1989; 7(5):411-6. PubMed ID: 2620246
[TBL] [Abstract][Full Text] [Related]
14. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
15. An Innovative Therapeutic Option for the Treatment of Skeletal Sarcomas: Elimination of Osteo- and Ewing's Sarcoma Cells Using Physical Gas Plasma.
Jacoby JM; Strakeljahn S; Nitsch A; Bekeschus S; Hinz P; Mustea A; Ekkernkamp A; Tzvetkov MV; Haralambiev L; Stope MB
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585948
[TBL] [Abstract][Full Text] [Related]
16. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
González I; Andreu EJ; Panizo A; Inogés S; Fontalba A; Fernández-Luna JL; Gaboli M; Sierrasesúmaga L; Martín-Algarra S; Pardo J; Prósper F; de Alava E
Clin Cancer Res; 2004 Jan; 10(2):751-61. PubMed ID: 14760098
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the oncogenic fusion protein EWS-FLI1 causes G
Zöllner SK; Selvanathan SP; Graham GT; Commins RMT; Hong SH; Moseley E; Parks S; Haladyna JN; Erkizan HV; Dirksen U; Hogarty MD; Üren A; Toretsky JA
Sci Signal; 2017 Oct; 10(499):. PubMed ID: 28974650
[TBL] [Abstract][Full Text] [Related]
18. Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.
Ye C; Yu X; Zeng J; Dai M; Zhang B
Int J Oncol; 2017 Dec; 51(6):1785-1792. PubMed ID: 29039470
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.
Welch D; Kahen E; Fridley B; Brohl AS; Cubitt CL; Reed DR
PLoS One; 2019; 14(9):e0222228. PubMed ID: 31550266
[TBL] [Abstract][Full Text] [Related]
20. Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
Heinen TE; Dos Santos RP; da Rocha A; Dos Santos MP; Lopez PL; Silva Filho MA; Souza BK; Rivero LF; Becker RG; Gregianin LJ; Brunetto AL; Brunetto AT; de Farias CB; Roesler R
Oncotarget; 2016 Jun; 7(23):34860-80. PubMed ID: 27145455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
